scispace - formally typeset
A

Andreas Herrmann

Researcher at Humboldt University of Berlin

Publications -  371
Citations -  13813

Andreas Herrmann is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Membrane & Lipid bilayer fusion. The author has an hindex of 62, co-authored 369 publications receiving 12507 citations. Previous affiliations of Andreas Herrmann include Humboldt State University & Charité.

Papers
More filters
Journal ArticleDOI

High‐Fidelity Protein Targeting into Membrane Lipid Microdomains in Living Cells

TL;DR: Robust partitioning into lo phases was confirmed by using viral lipid mixtures and giant plasma membrane vesicles, and efficient protein targeting into lo and ld domains within the plasma membrane of living cells was demonstrated by single-molecule tracking, thus establishing a highly generic approach for exploring lipid microdomains in Situ.
Journal ArticleDOI

Parameters Influencing the Release of Tertiary Alcohols from the Surface of Spherical Dendrimers and Linear Stylomers by Neighbouring-Group-Assisted Hydrolysis of 2-Carbamoylbenzoates

TL;DR: An understanding of the physico-chemical parameters determining the local environment of the covalent-bond cleavage site is an important prerequisite to transfer the characteristics of small molecules to larger structures such as oligomers and polymers and thus to design efficient macromolecular conjugates for the controlled delivery of bioactive compounds.
Journal ArticleDOI

Conformational changes of the bacterial type I ATP-binding cassette importer HisQMP2 at distinct steps of the catalytic cycle.

TL;DR: Together, the data suggest similar conformational changes during the transport cycle as described for the maltose ABC transporter of Escherichia coli, despite distinct structural differences between both systems.
Journal ArticleDOI

RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.

TL;DR: Taken together, the otherwise clinically approved UBKIs regorafenib and sorafenIB possess high and broad-spectrum antiviral activity along with substantial robustness against resistance development and thus constitute attractive host-directed drug candidates against a range of viral infections including influenza.
Journal ArticleDOI

Plasma membrane asymmetry of lipid organization: fluorescence lifetime microscopy and correlation spectroscopy analysis

TL;DR: The results show that the combination of FLIM and ITIR-FCS with specific fluorescent lipid analogs is a powerful tool for investigating lateral and transbilayer characteristics of plasma membrane in live cell lines.